"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder"
The purpose of this study is to examine the efficacy, safety, and tolerability of CYB003 compared to matching placebo as adjunctive treatment in participants with MDD.
Aged 18 to 85 years inclusive, at Screening [+10]
Current or previously diagnosed schizophrenia spectrum or other psychotic disord... [+22]